Search





Search





Markets
/
Stocks
/
roiv
/

Roivant Sciences Ltd

ROIV

Add to Watchlist

33.910USD

-0.610-1.77%

Close 07-31 16:00（ET）Quotes delayed by 15 min

24.43BMarket Cap

LossP/E TTM

Roivant Sciences Ltd

33.910

-0.610-1.77%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

ROIV Cash Flow Statement

You can access the annual and quarterly cash flow statements of Roivant Sciences Ltd to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q4

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

5.07%-163.82M

5.20%-196.48M

30.41%-185.66M

-5.99%-204.38M

-59.11%-172.56M

1.52%-207.25M

-35.83%-266.81M

22.85%-192.83M

39.44%-108.46M

5.45%-210.45M

-3.58%-196.43M

0.85%-249.93M

-21.44%-179.09M

17.10%-222.59M

-57.24%-189.63M

-78.57%-252.08M

-39.03%-147.47M

-13.36%-268.49M

-23.00%-120.60M

-26.99%-141.17M

---106.07M

---236.86M

---98.05M

---111.17M

Net income from continuing operations

240.96%355.74M

-365.68%-313.70M

40.68%-166.04M

-576.45%-273.91M

-38.29%-252.38M

-97.67%118.08M

15.46%-279.92M

117.54%57.49M

-199.85%-182.50M

1417.93%5.07B

-4.81%-331.12M

7.33%-327.85M

79.11%-60.86M

-25.75%-384.90M

-40.01%-315.92M

-250.01%-353.78M

48.27%-291.31M

-11.06%-306.08M

-321.77%-225.64M

-1167.12%-101.08M

---563.16M

---275.60M

---53.50M

---7.98M

Operating gains losses

-55.23%638.00K

457.51%16.29M

-80.98%921.00K

-77.51%1.10M

-72.73%1.43M

-45.76%2.92M

-13.33%4.84M

-16.37%4.88M

-12.23%5.22M

4.54%5.38M

-27.94%5.59M

--5.84M

--5.95M

--5.15M

--7.75M

----

Other non-cash items

-11.65%-10.56M

95.85%-15.91M

95.41%-1.90M

-72.56%1.96M

-121.54%-9.46M

-982.52%-383.32M

-427.71%-41.39M

278.03%7.16M

132.70%43.89M

-139.54%-35.41M

201.17%12.63M

---4.02M

---134.21M

1364.42%89.56M

-94.18%4.19M

----

-100.00%0.00

-73.86%6.12M

72.59%72.11M

----

--290.17M

--23.40M

--41.78M

----

Change in working capital

-1843.06%-601.08M

117.65%9.37M

-31.38%7.08M

45.93%-37.17M

116.13%34.48M

-350.55%-53.10M

-39.80%10.31M

-95.04%-68.73M

-45.45%15.96M

250.95%21.20M

-38.81%17.13M

4.37%-35.24M

-31.85%29.25M

86.07%-14.04M

-71.59%27.99M

-232.21%-36.85M

-63.48%42.92M

-311.05%-100.79M

3472.98%98.51M

-3.88%-11.09M

--117.53M

---24.52M

--2.76M

---10.68M

-Change in receivables

---770.24M

----

-Change in other current assets

-45.07%11.04M

93.45%-2.73M

-206.35%-4.39M

100.78%128.00K

143.47%20.09M

-655.32%-41.72M

119.08%4.13M

-252.10%-16.33M

-7202.21%-46.22M

124.20%7.51M

---21.64M

---4.64M

---633.00K

---31.04M

----

-Change in other current liabilities

-212.54%-6.03M

229.77%8.30M

84.37%-3.21M

-100.58%-71.00K

115.56%5.36M

-123.32%-6.39M

-499.03%-20.51M

30.13%12.27M

-529.07%-34.45M

260.50%27.42M

133.35%5.14M

206.04%9.43M

-52.45%8.03M

112.40%7.61M

-249.25%-15.41M

-32.26%3.08M

-83.54%16.88M

-88.36%-61.35M

27.96%10.32M

1159.91%4.55M

--102.54M

---32.57M

--8.07M

---429.00K

Cash from non-recurring investing activities

Cash from operating activities

5.07%-163.82M

5.20%-196.48M

30.41%-185.66M

-5.99%-204.38M

-59.11%-172.56M

1.52%-207.25M

-35.83%-266.81M

22.85%-192.83M

39.44%-108.46M

5.45%-210.45M

-3.58%-196.43M

0.85%-249.93M

-21.44%-179.09M

17.10%-222.59M

-57.24%-189.63M

-78.57%-252.08M

-39.03%-147.47M

-13.36%-268.49M

-23.00%-120.60M

-26.99%-141.17M

---106.07M

---236.86M

---98.05M

---111.17M

Investing cash flow

Net cash from continuing investing activities

55.49%1.26M

95.45%-4.93M

687.95%7.85M

318.13%4.04M

132.38%811.00K

97.93%-108.56M

262.18%996.00K

139.45%965.00K

-78.48%349.00K

-1030226.18%-5.23B

-91.13%275.00K

-94.60%403.00K

-74.10%1.62M

-91.64%508.00K

12.31%3.10M

218.90%7.46M

53.13%6.26M

5575.70%6.07M

111.90%2.76M

664.38%2.34M

--4.09M

--107.00K

--1.30M

--306.00K

Capital expenditures

55.49%1.26M

----

687.95%7.85M

318.13%4.04M

132.38%811.00K

414.65%1.83M

262.18%996.00K

139.45%965.00K

-78.48%349.00K

-30.12%355.00K

-91.13%275.00K

-94.60%403.00K

-74.10%1.62M

-91.64%508.00K

12.31%3.10M

218.90%7.46M

53.13%6.26M

5575.70%6.07M

111.90%2.76M

664.38%2.34M

--4.09M

--107.00K

--1.30M

--306.00K

Net cash flow from disposal of fixed assets

55.49%1.26M

95.45%-4.93M

687.95%7.85M

318.13%4.04M

132.38%811.00K

97.93%-108.56M

262.18%996.00K

139.45%965.00K

-78.48%349.00K

-1030226.18%-5.23B

-91.13%275.00K

-94.60%403.00K

-74.10%1.62M

-91.64%508.00K

12.31%3.10M

218.90%7.46M

53.13%6.26M

5575.70%6.07M

111.90%2.76M

664.38%2.34M

--4.09M

--107.00K

--1.30M

--306.00K

Net cash flow from business transactions

-105.90%-4.42M

-100.00%0.00

----

9419.15%74.93M

--44.05M

405.11%110.39M

----

---804.00K

100.00%0.00

-900.80%-36.18M

----

--0.00

---3.09M

---3.62M

----

--0.00

--21.44M

---19.09M

Net cash flow from investment products

-82.08%179.17M

-64.49%107.05M

103.77%128.27M

---1.08B

--1.00B

--301.46M

---3.40B

----

--0.00

----

--0.00

--320.17M

----

Net cash flow from other investing activities

-100.00%0.00

---2.52M

----

-99.02%79.00K

--0.00

-100.00%0.00

-92.98%8.08M

-100.00%0.00

100.00%3.00K

--508.00K

20430.30%115.17M

--88.00K

---140.14M

----

--561.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

-83.85%173.49M

-75.89%109.47M

103.66%120.42M

-112409.43%-1.09B

15405.11%1.07B

-91.32%454.07M

-8935.68%-3.29B

-1019.05%-965.00K

-93.90%6.93M

149147.02%5.23B

75.18%-36.45M

101.41%105.00K

2091.46%113.55M

42.19%-3.51M

-146.27%-146.85M

-218.90%-7.46M

-39.41%-5.70M

-5575.70%-6.07M

17128.38%317.41M

90.88%-2.34M

---4.09M

---107.00K

---1.86M

---25.64M

Financing cash flow

Cash flow from continuous financing activities

61.18%-68.78M

220.24%328.19M

157.38%62.59M

71.58%-187.77M

-443.01%-177.15M

-215.34%-272.95M

-152.47%-109.07M

-8935.31%-660.62M

-115.51%-32.62M

53.17%236.64M

2931.66%207.87M

-94.73%7.48M

19557.20%210.33M

1934.42%154.50M

-102.42%-7.34M

1290.56%141.98M

-98.92%1.07M

-1915.09%-8.42M

72.73%303.93M

-94.36%10.21M

--98.71M

--464.00K

--175.96M

--181.13M

Net cash flow from debt Issuance/repayment

----

100.00%0.00

-540.71%-49.09M

75.79%-1.83M

76.58%-1.83M

4.62%-7.67M

-3.22%-7.66M

-3.12%-7.57M

-105.12%-7.81M

---8.04M

---7.42M

---7.34M

930.08%152.56M

--0.00

--14.81M

----

--0.00

Net cash flow from common stock issuance/repurchase

39.12%-111.21M

179.56%193.60M

100.00%0.00

67.88%-208.29M

---182.66M

-201.93%-243.35M

-153.07%-106.05M

---648.38M

-100.00%0.00

46.95%238.73M

--199.82M

----

9568.27%217.25M

--162.46M

----

-97.73%2.25M

100.00%0.00

-101.28%-2.25M

----

--99.00M

---261.00K

--175.84M

--181.07M

Proceeds from stock option exercised by employees

294.61%51.19M

323.96%119.19M

850.30%69.07M

1223.51%30.06M

254.88%12.97M

216.57%28.11M

-66.51%7.27M

-89.20%2.27M

42.72%3.66M

1460.81%8.88M

--21.70M

--21.03M

--2.56M

--569.00K

----

-100.00%0.00

----

--0.00

--725.00K

--119.00K

--63.00K

Proceeds from issuance of warrants

----

--0.00

----

--0.00

---36.00K

----

Net cash flow from other financing activities

-17.30%-8.75M

-176.53%-23.86M

23.35%-6.48M

24.78%-9.53M

73.93%-7.46M

-160.40%-8.63M

-39.87%-8.46M

-120.67%-12.67M

-1888.46%-28.61M

-197.66%-3.31M

---6.04M

45.71%-5.74M

-22.26%-1.44M

86.78%-1.11M

-100.00%0.00

-129.98%-10.58M

-311.54%-1.18M

---8.42M

--306.18M

---4.60M

---286.00K

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

61.18%-68.78M

220.24%328.19M

157.38%62.59M

71.58%-187.77M

-443.01%-177.15M

-215.34%-272.95M

-152.47%-109.07M

-8935.31%-660.62M

-115.51%-32.62M

53.17%236.64M

2931.66%207.87M

-94.73%7.48M

19557.20%210.33M

1934.42%154.50M

-102.42%-7.34M

1290.56%141.98M

-98.92%1.07M

-1915.09%-8.42M

72.73%303.93M

-94.36%10.21M

--98.71M

--464.00K

--175.96M

--181.13M

Net cash flow

Beginning cash balance

-25.62%1.49B

-38.53%1.25B

-78.07%1.25B

-58.39%2.73B

-70.06%2.00B

42.56%2.03B

292.74%5.69B

287.12%6.55B

333.83%6.69B

-11.75%1.42B

-25.90%1.45B

-18.41%1.69B

-30.78%1.54B

-35.73%1.61B

-2.58%1.96B

-3.16%2.07B

3.39%2.23B

5.00%2.51B

-13.19%2.01B

-5.62%2.14B

--2.15B

--2.39B

--2.31B

--2.27B

Current period cash flow changes

-107.98%-57.79M

988.44%241.61M

99.96%-1.45M

-72.32%-1.48B

636.25%723.99M

-100.52%-27.20M

-13748.95%-3.66B

-253.51%-857.15M

-189.36%-135.01M

7448.62%5.26B

92.30%-26.46M

-106.24%-242.47M

199.33%151.08M

74.70%-71.61M

-168.66%-343.82M

11.80%-117.56M

-1229.21%-152.10M

-19.66%-282.99M

558.47%500.75M

-400.75%-133.30M

---11.44M

---236.50M

--76.05M

--44.32M

Effect of exchange rate changes

369.12%1.32M

140.30%430.00K

-76.09%1.21M

129.74%815.00K

42.81%-489.00K

-135.08%-1.07M

446.84%5.04M

-2241.88%-2.74M

-113.61%-855.00K

--3.04M

---1.45M

---117.00K

--6.28M

----

Ending cash balance

-47.50%1.43B

-25.62%1.49B

-38.53%1.25B

-78.07%1.25B

-58.39%2.73B

-70.06%2.00B

42.56%2.03B

292.74%5.69B

287.12%6.55B

333.83%6.69B

-11.75%1.42B

-25.90%1.45B

-18.41%1.69B

-30.78%1.54B

-35.73%1.61B

-2.58%1.96B

-3.16%2.07B

3.39%2.23B

5.00%2.51B

-13.19%2.01B

--2.14B

--2.15B

--2.39B

--2.31B

Free cash flow

4.79%-165.08M

6.02%-196.48M

27.74%-193.51M

-7.55%-208.42M

-59.34%-173.38M

0.82%-209.08M

-36.15%-267.80M

22.59%-193.79M

39.79%-108.81M

5.51%-210.81M

-2.06%-196.70M

3.55%-250.34M

-17.55%-180.71M

18.74%-223.10M

-56.24%-192.73M

-80.85%-259.54M

-39.56%-153.73M

-15.87%-274.57M

-24.17%-123.36M

-28.74%-143.51M

---110.16M

---236.97M

---99.35M

---111.47M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Roivant Sciences Ltd Generate?



Roivant Sciences Ltd generated -750.35M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Roivant Sciences Ltd's Operating Cash Flow Change Year Over Year?



Roivant Sciences Ltd's operating cash flow increased by 10.61% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Roivant Sciences Ltd Spend on Capital Expenditures?



Roivant Sciences Ltd spent 8.21M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Roivant Sciences Ltd's Financing Cash Flow Changed?



Roivant Sciences Ltd used 134.24M in financing activities in the latest quarter.

What is free cash flow and why does it matter for ROIV?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Roivant Sciences Ltd’s free cash flow in the latest quarter?



Free cash flow was -758.56M reflecting a 10.13% change from the previous year.